Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “the Efficacy and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07178678
What this trial is testing

Evaluation of the Safety and Efficacy of NeuroEPO in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Mild Alzheimer's DiseaseModerate Alzheimer's Disease
University of Saskatchewan 90
Large-scale testing (Phase 3)Looking for participantsNCT07502443
What this trial is testing

Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2

Who this might be right for
Narcolepsy Type 2
Alkermes, Inc. 176
Large-scale testing (Phase 3)Study completedNCT01261143
What this trial is testing

Randomized, Double-blind Study to Assess the Efficacy and Safety of α-lipoic Acid Versus BK-C-0701 in Subjects With Diabetic Neuropathy

Who this might be right for
Diabetic Neuropathies
Bukwang Pharmaceutical 164
Testing effectiveness (Phase 2)UnknownNCT04367025
What this trial is testing

Efficacy and Safety of Perioperative Chemotherapy Plus PD-1 Antibody in Gastric Cancer

Who this might be right for
Gastric Cancer
Chinese PLA General Hospital 70
Large-scale testing (Phase 3)Study completedNCT02604017
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection

Who this might be right for
Chronic Hepatitis CHepatitis C VirusHCV
AbbVie 703
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07239440
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Who this might be right for
Diabete Mellitus
Dong-A ST Co., Ltd. 288
Not applicableStudy completedNCT04889950
What this trial is testing

Evaluate the Safety and Effectiveness of The Tixel Fractional System in the Treatment of Meibomian Gland Disfunction

Who this might be right for
Dry Eye SyndromesDry EyeMeibomian Gland Dysfunction
Novoxel Ltd. 30
Not applicableNot Yet RecruitingNCT06708650
What this trial is testing

Combination of SFRT, PD-L1 Inhibitor, and Anti-VEGF in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaRadiotherapyPD-1 Inhibitors
Guiping People's Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT05803018
What this trial is testing

BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies

Who this might be right for
Gynecological Malignant TumorSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 38
Testing effectiveness (Phase 2)UnknownNCT00964626
What this trial is testing

Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer

Who this might be right for
Ovarian Cancer
Russian Academy of Medical Sciences 60
Testing effectiveness (Phase 2)Looking for participantsNCT06214143
What this trial is testing

A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Shanghai Pharmaceuticals Holding Co., Ltd 68
Not applicableLooking for participantsNCT03671889
What this trial is testing

ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease

Who this might be right for
Alzheimer Disease
InSightec 50
Large-scale testing (Phase 3)Study completedNCT01147289
What this trial is testing

Efficacy and Safety of Injectable Association of Dexamethasone, Dipyrone and Hydrocobalamin in Lumbar Sciatic Pain

Who this might be right for
Lumbar Sciatic Pain
Eurofarma Laboratorios S.A. 280
Testing effectiveness (Phase 2)Active Not RecruitingNCT04821089
What this trial is testing

Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines

Who this might be right for
Moderate to Severe Upper Facial Lines
Ipsen 727
Large-scale testing (Phase 3)Study completedNCT00781391
What this trial is testing

Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation

Who this might be right for
StrokeAtrial FibrillationEmbolism
Daiichi Sankyo 21,105
Large-scale testing (Phase 3)Ended earlyNCT05788497
What this trial is testing

Efficacy and Safety of Hemorrane Plus Versus Hemorrane and Versus Placebo in Patients With Uncomplicated Haemorrhoids

Who this might be right for
Haemorrhoids Without Complication
Faes Farma, S.A. 21
Testing effectiveness (Phase 2)Study completedNCT01740297
What this trial is testing

Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma

Who this might be right for
Melanoma
Amgen 217
Testing effectiveness (Phase 2)Study completedNCT01593410
What this trial is testing

Study of Lenalidomide and Low-Dose Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 194
Testing effectiveness (Phase 2)Ended earlyNCT06679582
What this trial is testing

Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Sutro Biopharma, Inc. 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT04515238
What this trial is testing

Sequential Regimen of Bendamustine Followed by Obinutuzumab (GA101), Zanubrutinib (BGB-3111) and Venetoclax (ABT-199) in Patients With Relapsed/Refractory CLL

Who this might be right for
Chronic Lymphoid Leukemia
German CLL Study Group 42
Next Page